MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
69.2 M |
Market Cap[1] |
$ 4.64 B |
EBITDA (LTM) |
$ 416 M |
P/E (LTM) |
14.8 |
P/S (LTM) |
3.05 |
EPS (LTM) |
4.51 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 19.02 | 0.21 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
$ 20.99 | 1.77 % | $ 226 M | Nasdaq Global Market |  China |
 |
Co-Diagnostics
CODX
|
$ 0.17 | -3.71 % | $ 4.99 M | Nasdaq Capital Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 39.06 | -0.64 % | $ 1.08 B | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 230.1 | -0.25 % | $ 168 B | NYSE,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.95 | 2.34 % | $ 311 M | Nasdaq Capital Market | Israel |
 |
BioNano Genomics
BNGO
|
$ 1.52 | 1.23 % | $ 1.93 M | Nasdaq Capital Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 101.89 | -0.01 % | $ 18.9 B | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DexCom
DXCM
|
$ 66.73 | -0.5 % | $ 25.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 26.31 | -0.7 % | $ 795 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 18.96 | -0.6 % | $ 1.02 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 99.66 | -0.26 % | $ 3.93 B | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.14 | 0.64 % | $ 100 K | Nasdaq Capital Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 226.62 | -0.47 % | $ 41.1 B | NYSE,SPB | USA |
 |
Guardant Health
GH
|
$ 102.42 | 1.81 % | $ 12.6 B | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 11.95 | -2.29 % | $ 1.51 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 6.14 | -0.57 % | $ 556 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.5 | -5.46 % | $ 2.42 M | Nasdaq Global Select Market | USA |
 |
Neogen Corporation
NEOG
|
$ 7.07 | 0.21 % | $ 1.53 B | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.22 | -0.62 % | $ 20 B | NYSE |  Niderland |
 |
Personalis
PSNL
|
$ 8.02 | 0.63 % | $ 475 M | Nasdaq Global Select Market | USA |
 |
Quidel Corporation
QDEL
|
$ 28.81 | -1.67 % | $ 1.21 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.73 | 0.43 % | $ 460 M | Nasdaq Global Select Market | USA |
 |
RadNet
RDNT
|
$ 71.37 | -0.17 % | $ 5.21 B | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 131.22 | -1.15 % | $ 20.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 200.86 | -0.55 % | $ 10.3 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
$ 45.87 | -0.91 % | $ 1.84 B | Nasdaq Capital Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 174.42 | -0.61 % | $ 19.4 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 6.78 | 0.86 % | $ 879 M | Nasdaq Global Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
$ 251.89 | -0.47 % | $ 21.1 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 182.34 | -0.36 % | $ 15 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 679.3 | -0.44 % | $ 56 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.